SHIP1 MODULATORS AND METHODS RELATED THERETO
Compounds of formula (II): wherein A, R1, R2, R5 and R13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds have activity as SHIP1 mod...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
05.05.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Compounds of formula (II): wherein A, R1, R2, R5 and R13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds have activity as SHIP1 modulators, and thus may be useful in treating a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of the invention are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof.
Compuestos de fórmula (II): (Ver formula) en donde A, R1, R2, R5 y R13 se describen en este documento, o un estereoisómero, enantiómero o tautómero de los mismos o mezclas de los mismos, o una sal o solvato farmaceuticamente aceptables de los mismos, se describen en este documento, asi como otros compuestos; estos compuestos tienen actividad como moduladores del SHIP1 y así pueden ser útiles en el tratamiento de una variedad de enfermedades, trastornos o afecciones que se beneficiarían de la modulación de SHIP1; también se describen composiciones que comprenden un compuesto de la invención, así como métodos de modulación de SHIP1 por administración de dichos compuestos a un animal en necesidad de los mismos. |
---|---|
AbstractList | Compounds of formula (II): wherein A, R1, R2, R5 and R13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds have activity as SHIP1 modulators, and thus may be useful in treating a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of the invention are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof.
Compuestos de fórmula (II): (Ver formula) en donde A, R1, R2, R5 y R13 se describen en este documento, o un estereoisómero, enantiómero o tautómero de los mismos o mezclas de los mismos, o una sal o solvato farmaceuticamente aceptables de los mismos, se describen en este documento, asi como otros compuestos; estos compuestos tienen actividad como moduladores del SHIP1 y así pueden ser útiles en el tratamiento de una variedad de enfermedades, trastornos o afecciones que se beneficiarían de la modulación de SHIP1; también se describen composiciones que comprenden un compuesto de la invención, así como métodos de modulación de SHIP1 por administración de dichos compuestos a un animal en necesidad de los mismos. |
Author | PETTIGREW, JEREMY D RAYMOND, JEFFERY R HARWIG, CURTIS BOGUCKI, DAVID MACKENZIE, LLOYD F MACRURY, THOMAS B |
Author_xml | – fullname: PETTIGREW, JEREMY D – fullname: HARWIG, CURTIS – fullname: MACKENZIE, LLOYD F – fullname: BOGUCKI, DAVID – fullname: RAYMOND, JEFFERY R – fullname: MACRURY, THOMAS B |
BookMark | eNrjYmDJy89L5WTQCfbwDDBU8PV3CfVxDPEPClZw9HNR8HUN8fB3CVYIcgUKuroohHi4BrmG-PMwsKYl5hSn8kJpbgYlN9cQZw_d1IL8-NTigsTk1LzUknjfCCMDQ1MDQyNDQ0NHY6IUAQDQRCdJ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | MODULADORES DE SHIP1 Y MÉTODOS RELACIONADOS CON ÉSTOS. |
ExternalDocumentID | MX2015012111A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_MX2015012111A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:48:31 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_MX2015012111A3 |
Notes | Application Number: MX20150012111 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160505&DB=EPODOC&CC=MX&NR=2015012111A |
ParticipantIDs | epo_espacenet_MX2015012111A |
PublicationCentury | 2000 |
PublicationDate | 20160505 |
PublicationDateYYYYMMDD | 2016-05-05 |
PublicationDate_xml | – month: 05 year: 2016 text: 20160505 day: 05 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | AQUINOX PHARMACEUTICALS (CANADA) INC |
RelatedCompanies_xml | – name: AQUINOX PHARMACEUTICALS (CANADA) INC |
Score | 2.8972013 |
Snippet | Compounds of formula (II): wherein A, R1, R2, R5 and R13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | SHIP1 MODULATORS AND METHODS RELATED THERETO |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160505&DB=EPODOC&locale=&CC=MX&NR=2015012111A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH_MKepNp6JOJYj0ZHFrm6w5FNmalip2HV0nvY21y0AEHbbiv-9L2HSn3UICL8mD3_tI3gfAXadgVol2hukUiCaHd2yT07ltSiqZhfbGjPdUcnI8ZNHEec5p3oD3dS6MrhP6o4sjIqJKxHut5fXy_xFL6NjK6qF4w6nPxzDzhLHyjrtMNWYzxMALRolIfMP3vTg3hqlao7qcWbe_A7toR_dU_FfwOlBpKctNnRIewd4IyX3Ux9CQVQsO_HXrtRbsx6sfbxyuwFedwP04ehp1SZyIyUs_S9Ix6Q8FiYMsSsSYqN4XKIVIFgVpkCWncBsGmR-ZuO3075LTON84on0GTfT-5TkQWlpUcncmJZ-hccVcxhaMWoteaRfcpc4FtLcQuty62oZDxTMdv0evoFl_fctr1LF1caN58wtDOnnE |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkWdH0WkTxbXj2Ttw5Ct6eh0aceWSd_GWjMQQYer-O97CZvuaW8hB5fk4HcfSe4O4K6ZU6dAP8PyckSTFzRdKyCvriWJpA76G7OgpZKTeULjifeUkawC7-tcGF0n9EcXR0REFYj3Uuvrxf8lFtN_K5cP-RtOfT72RJuZq-jYpqoxm8m67WiYsjQ0w7DNMzMZKRrR5czszg7soo_tq0L70UtXpaUsNm1K7xD2hsjuozyCilzWoRauW6_VYZ-vXrxxuALf8hjux3F_aBs8ZZNBR6SjsdFJmMEjEadsbKjeF6iFDBFHo0ikJ3Dbi0QYW7js9O-QU55tbNE9hSpG__IMDFI4RAb-TMpghs4V9SmdU-LMW4WbBz7xzqGxhdHFVuoN1GLBB9NBP3luwIGSn_7LRy6hWn59yyu0t2V-reX0CyCefLQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SHIP1+MODULATORS+AND+METHODS+RELATED+THERETO&rft.inventor=PETTIGREW%2C+JEREMY+D&rft.inventor=HARWIG%2C+CURTIS&rft.inventor=MACKENZIE%2C+LLOYD+F&rft.inventor=BOGUCKI%2C+DAVID&rft.inventor=RAYMOND%2C+JEFFERY+R&rft.inventor=MACRURY%2C+THOMAS+B&rft.date=2016-05-05&rft.externalDBID=A&rft.externalDocID=MX2015012111A |